• Explore /
  • Poster
  • / A phase I/II study for panitumumab combined with TAS-102 in patients with <i>RAS</i> wild-type metastatic colorectal cancer (APOLLON study): Phase I results.

A phase I/II study for panitumumab combined with TAS-102 in patients with RAS wild-type metastatic colorectal cancer (APOLLON study): Phase I results.

Abstract Poster

Authors

null

Takeshi Kato

Department of Surgery, Kansai Rosai Hospital, Amagasaki, Japan

Takeshi Kato , Yoshinori Kagawa , Yoshito Komatsu , Eiji Oki , Takayuki Yoshino , Kentaro Yamazaki , Hirofumi Yasui , Hironaga Satake , Kazunori Shibuya , Koji Oba , Kensei Yamaguchi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

02613221

Citation

J Clin Oncol 35, 2017 (suppl 4S; abstract 770)

DOI

10.1200/JCO.2017.35.4_suppl.770

Abstract #

770

Poster Bd #

M14

Abstract Disclosures

Similar Posters

First Author: Yoshito Komatsu

First Author: Seiichiro Mitani

First Author: Antoine Adenis

First Author: Hirokazu Shoji